Financial health
- Total debt ($15.2B) exceeds cash ($15.0B); net debt is $209M.
Shareholder returns
- Dividends have been paid for 10 consecutive years, consuming 12.0% of earnings.
- The dividend has declined 3.9% per year over the past 5 years.
14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | — | $3.6B | — | — | — | $15.2B | $15.0B |
| 2024 | — | $3.5B | — | — | — | $15.5B | $14.7B |
| 2023 | — | $2.2B | — | — | — | $16.0B | $14.3B |
| 2022 | — | $3.0B | — | — | — | $14.2B | $10.3B |
| 2021 | — | $4.2B | — | — | — | $14.5B | $8.3B |
| 2020 | — | $1.4B | — | — | — | $15.8B | $11.5B |
| 2019 | — | $3.7B | — | — | — | $19.9B | $12.1B |
| 2018 | — | $2.8B | — | — | — | $24.0B | $9.4B |
| 2017 | — | $1.9B | — | — | — | $20.8B | $11.6B |
| 2016 | — | $2.3B | — | — | — | $20.1B | $9.3B |
| 2015 | — | $2.2B | — | — | — | $24.3B | $12.3B |
| 2014 | — | $2.1B | — | — | — | — | $11.8B |
| 2013 | — | $2.0B | — | — | — | — | $2.3B |
| 2012 | — | $2.1B | — | — | — | — | $1.3B |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | $805M | — | — | — | $16.4B | $20.6B |
| Dec '25 | — | $751M | — | — | — | $15.2B | $15.0B |
| Sep '25 | — | $1.1B | — | — | — | $14.4B | $16.2B |
| Jun '25 | — | $967M | — | — | — | $16.0B | $19.5B |
| Mar '25 | — | $757M | — | — | — | $17.0B | $21.6B |
| Dec '24 | — | $774M | — | — | — | $15.5B | $14.7B |
| Sep '24 | — | $789M | — | — | — | $15.6B | $17.9B |
| Jun '24 | — | $643M | — | — | — | $15.6B | $18.6B |
| Mar '24 | — | $1.3B | — | — | — | $16.1B | $20.0B |
| Dec '23 | — | $440M | — | — | — | $16.0B | $14.3B |
| Sep '23 | — | $628M | — | — | — | $15.2B | $15.6B |
| Jun '23 | — | $569M | — | — | — | $14.2B | $12.7B |
| Mar '23 | — | $601M | — | — | — | $14.9B | $15.3B |
| Dec '22 | — | $577M | — | — | — | $14.2B | $10.3B |
| Sep '22 | — | $703M | — | — | — | $14.3B | $12.0B |
| Jun '22 | — | $804M | — | — | — | $12.2B | $10.7B |
| Mar '22 | — | $932M | — | — | — | $13.4B | $10.5B |
| Dec '21 | — | $813M | — | — | — | $14.5B | $8.3B |
| Sep '21 | — | $1.1B | — | — | — | $12.8B | $9.8B |
| Jun '21 | — | $1.2B | — | — | — | $13.5B | $11.1B |
How the market has priced SYF against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
See the revenue and net-income charts above for Synchrony Financial's multi-year trend.
As of FY2025, Synchrony Financial reported $15.2B of total debt against $15.0B of cash.
In FY2025, gross margin was —, operating margin —, and net margin —.
As of Jun '26, Synchrony Financial traded at a price-to-earnings ratio of about 7.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.